Found 280 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query ec: 3.4.21.6

Total Genus Sequence Length pdb Title
4 42 1ccfA How an epidermal growth factor (egf)-like domain binds calcium-high resolution nmr structure of the calcium form of the nh2-terminal egf-like domain in coagulation factor x
4 42 1apoA Three-dimensional structure of the apo form of the n-terminal egf-like module of blood coagulation factor x as determined by nmr spectroscopy and simulated folding
11 51 5voeL Desgla-xas195a bound to aptamer 11f7t
63 233 5vofH Desgla-xas195a bound to aptamer 11f7t and rivaroxaban
12 56 3sw2A X-ray crystal structure of human fxa in complex with 6-chloro-n-((3s)-2-oxo-1-(2-oxo-2-((5s)-8-oxo-5,6-dihydro-1h-1,5-methanopyrido[1,2-a][1,5]diazocin-3(2h,4h,8h)-yl)ethyl)piperidin-3-yl)naphthalene-2-sulfonamide
11 51 5vofL Desgla-xas195a bound to aptamer 11f7t and rivaroxaban
62 233 5voeH Desgla-xas195a bound to aptamer 11f7t
0 18 5jtcB Aspartyl/asparaginyl beta-hydroxylase (asph)oxygenase and tpr domains in complex with manganese, 2,4-pyridine dicarboxylate and factor x substrate peptide fragment(39mer-4ser)
10 51 5k0hB Human factor xa in complex with synthetic inhibitor benzylsulfonyl-dser(benzyl)-gly-4-amidinobenzylamide
61 234 5k0hA Human factor xa in complex with synthetic inhibitor benzylsulfonyl-dser(benzyl)-gly-4-amidinobenzylamide
12 52 4zhaB Factor xa complex with gtc000102
58 234 4btiB Factor xa in complex with the dual thrombin-fxa inhibitor 58.
54 234 4btuB Factor xa in complex with the dual thrombin-fxa inhibitor 57.
13 53 4btuA Factor xa in complex with the dual thrombin-fxa inhibitor 57.
10 53 4btiA Factor xa in complex with the dual thrombin-fxa inhibitor 58.
11 51 4bttA Factor xa in complex with the dual thrombin-fxa inhibitor 31.
55 234 4bttB Factor xa in complex with the dual thrombin-fxa inhibitor 31.
11 53 4a7iA Factor xa in complex with a potent 2-amino-ethane sulfonamide inhibitor
60 234 4a7iB Factor xa in complex with a potent 2-amino-ethane sulfonamide inhibitor
12 54 3tk5B Factor xa in complex with d102-4380
12 54 3tk6B Factor xa in complex with d46-5241
63 233 3tk6A Factor xa in complex with d46-5241
60 233 3tk5A Factor xa in complex with d102-4380
58 233 3sw2B X-ray crystal structure of human fxa in complex with 6-chloro-n-((3s)-2-oxo-1-(2-oxo-2-((5s)-8-oxo-5,6-dihydro-1h-1,5-methanopyrido[1,2-a][1,5]diazocin-3(2h,4h,8h)-yl)ethyl)piperidin-3-yl)naphthalene-2-sulfonamide
59 234 4zh8A Factor xa complex with gtc000006
60 234 4zhaA Factor xa complex with gtc000102
12 52 4zh8B Factor xa complex with gtc000006
60 234 4y76A Factor xa complex with gtc000401
61 234 4y7bA Factor xa complex with gtc000441
60 234 4y71A Factor xa complex with gtc000398
12 52 4y6dB Factor xa complex with gtc000101
12 53 4y7bB Factor xa complex with gtc000441
12 52 4y71B Factor xa complex with gtc000398
13 53 4y7aB Factor xa complex with gtc000422
68 234 4y7aA Factor xa complex with gtc000422
12 53 4y76B Factor xa complex with gtc000401
61 234 4y79A Factor xa complex with gtc000406
12 53 4y79B Factor xa complex with gtc000406
64 234 4y6dA Factor xa complex with gtc000101
62 233 3q3kA Factor xa in complex with a phenylenediamine derivative
12 52 3q3kB Factor xa in complex with a phenylenediamine derivative
12 52 3m36L Factor xa in complex with the inhibitor 1-[3-(aminomethyl)phenyl]-n-[3-fluoro-2'-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (dpc423)
13 52 3m37L Factor xa in complex with the inhibitor 1-[2-(aminomethyl)phenyl]-n-(3-fluoro-2'-sulfamoylbiphenyl-4-yl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (dpc602)
61 234 3m36A Factor xa in complex with the inhibitor 1-[3-(aminomethyl)phenyl]-n-[3-fluoro-2'-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (dpc423)
58 234 3m37A Factor xa in complex with the inhibitor 1-[2-(aminomethyl)phenyl]-n-(3-fluoro-2'-sulfamoylbiphenyl-4-yl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (dpc602)
12 51 3liwB Factor xa in complex with (r)-2-(1-adamantylcarbamoylamino)-3-(3-carbamidoyl-phenyl)-n-phenethyl-propionic acid amide
57 234 3liwA Factor xa in complex with (r)-2-(1-adamantylcarbamoylamino)-3-(3-carbamidoyl-phenyl)-n-phenethyl-propionic acid amide
13 52 3kqeL Factor xa in complex with the inhibitor 3-methyl-1-(3-(5- oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2'- (pyrrolidin-1-ylmethyl)biphenyl-4-yl)-5,6-dihydro-1h- pyrazolo[3,4-c]pyridin-7(4h)-one
60 234 3kqbA Factor xa in complex with the inhibitor n-(3-fluoro-2'- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h- 1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-1h- pyrazole-5-carboxamide
12 50 3kl6B Discovery of tetrahydropyrimidin-2(1h)-one derivative tak-442: a potent, selective and orally active factor xa inhibitor